# QuidelOrtho Corp (QDEL)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/quidelortho-corp/ JSON: https://steadybase.io/company/quidelortho-corp.json Checked Nov 10, 2026. Latest filing read: Nov 4, 2026.

## Company

- Legal name: QuidelOrtho Corp
- Ticker: QDEL (Nasdaq)
- SEC CIK: 0001906324
- Industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Headquarters: San Diego, CA
- Fiscal year ends: January 1
- SEC filer category: Large accelerated filer
- Website: quidelortho.com
- LinkedIn: https://www.linkedin.com/company/quidelortho
- Next earnings date: Feb 4, 2027 (estimated from past 8-K timing)

## Key facts

- Revenue: $2.7B for the fiscal year ended Dec 28, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/0001906324-26-000008-index.html
- Operating income: -$919.2M for the fiscal year ended Dec 28, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/0001906324-26-000008-index.html
- Net income: -$1.1B for the fiscal year ended Dec 28, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/0001906324-26-000008-index.html
- SG&A: $746.3M for the fiscal year ended Dec 28, 2025 (10-K filed Feb 19, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/0001906324-26-000008-index.html
- Employees: 6,500 as of Dec 28, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm
- Shares outstanding: 68,612,588 as of Oct 28, 2026 (10-Q filed Nov 4, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000042/0001906324-26-000042-index.html
- Auditor: Kpmg LLP, Short Hills, New Jersey, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm

## Business

All references to “the Company,” “we,” “our” and “us” in this Annual Report refer to QuidelOrtho Corporation (“QuidelOrtho”) and its subsidiaries. References to “fiscal year ended 2025,” “fiscal year ended 2024” and “fiscal year ended 2023” in this Annual Report refer to the Company’s fiscal years ended December 28, 2025, December 29, 2024 and December 31, 2023, respectively. Refer to the Summary of Abbreviated Terms at the end of this Annual Report for definitions of terms used throughout this Annual Report.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 28, 2025 | $2.7B | -$919.2M | -$1.1B | $746.3M |
| Dec 29, 2024 | $2.8B | -$2.0B | -$2.1B | $766.8M |
| Dec 31, 2023 | $3.0B | $139.1M | -$10.1M | $763.2M |
| Jan 1, 2023 | $3.3B | $843.7M | $548.7M | $621.0M |
| Jan 2, 2022 | $1.7B | $906.0M | $704.2M | $239.6M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/quidelortho-corp.json

## Officers and directors

- Brian J. Blaser, President and Chief Executive Officer of QuidelOrtho. LinkedIn: https://linkedin.com/in/brian-j-blaser-443503159. Source: 8-K filed Nov 3, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000040/qdel9272026ex991earningsre.htm
- Micah W. Young, Chief Financial Officer. Source: Form 4 filed Jul 16, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000171787126000006/0001717871-26-000006-index.htm
- Micah Young, Chief Financial Officer. LinkedIn: https://www.linkedin.com/in/micah-young-53572219. Source: 8-K filed Jun 23, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000028/qdel-20260622.htm
- Joseph M. Busky, Chief Financial Officer. Source: Form 4 filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000138509126000012/0001385091-26-000012-index.htm
- Ronald Lee Bowman, Chief Human Resources Officer. Source: Form 4 filed Sep 17, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000203623826000005/0002036238-26-000005-index.htm
- Bryan Michael Hanson, EVP Global Port. Mgmt & Mkting. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000212361826000011/0002123618-26-000011-index.htm
- Philip D. McLellan, Chief Operations Officer. Source: Form 4 filed Apr 28, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000204579926000008/0002045799-26-000008-index.htm
- Nathaniel Sisitsky, Chief Legal Officer. Source: Form 4 filed Apr 22, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000122573826000007/0001225738-26-000007-index.htm
- Jonathan Philip Siegrist, EVP of R&D & CTO. Source: Form 4 filed Feb 3, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000204032126000004/0002040321-26-000004-index.htm
- Ann D. Rhoads, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Bryan M. Hanson, Named in proxy. LinkedIn: https://linkedin.com/in/bryan-hanson-33477ab. Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Edward L. Michael, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Evelyn S. Dilsaver, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- John R. Chiminski, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Jonathan P. Siegrist, Named in proxy. LinkedIn: https://linkedin.com/in/siegristj. Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Joseph D. Wilkins Jr., Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Kenneth J. Widder, M.D., Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Lee Bowman, Named in proxy. Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Mary Lake Polan, M.D., Ph.D., M.P.H., Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- Nathaniel B. Sisitsky, Named in proxy. LinkedIn: https://linkedin.com/in/nathaniel-sisitsky-29b99747. Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm
- R. Scott Huennekens, Board member (per proxy). Source: DEF 14A filed Apr 27, 2026, https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm

## Recent 8-K events

- Nov 3, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000040/qdel-20261103.htm
- Sep 23, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000036/qdel-20260923.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000032/qdel-20260806.htm
- Jun 23, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000028/qdel-20260622.htm
- Jun 16, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1906324/000119312526272707/d113744d8k.htm
- May 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000023/qdel-20260505.htm
- Apr 15, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000013/qdel-20260415.htm
- Mar 24, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000119312526120684/d89902d8k.htm
- Feb 13, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1906324/000119312526051461/d97103d8k.htm
- Feb 11, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000003/qdel-20260211.htm

## Insider trades (Form 4)

- Feb 13, 2026: Brian J. Blaser (President and CEO) bought 10,540 shares, about $248,639. Source: https://www.sec.gov/Archives/edgar/data/1906324/000149228926000006/0001492289-26-000006-index.htm
- Feb 13, 2026: Joseph M. Busky (Chief Financial Officer) bought 3,370 shares, about $79,734. Source: https://www.sec.gov/Archives/edgar/data/1906324/000138509126000008/0001385091-26-000008-index.htm
- Feb 13, 2026: Matthew Strobeck (Director) bought 10,000 shares, about $239,600. Source: https://www.sec.gov/Archives/edgar/data/1906324/000137783226000003/0001377832-26-000003-index.htm
- Dec 10, 2025: Ann D. Rhoads (Director) bought 750 shares, about $21,210. Source: https://www.sec.gov/Archives/edgar/data/1906324/000125025225000004/0001250252-25-000004-index.htm
- Nov 26, 2025: Joseph D. Wilkins Jr. (Director) bought 370 shares, about $10,345. Source: https://www.sec.gov/Archives/edgar/data/1906324/000184876025000004/0001848760-25-000004-index.htm
- Nov 25, 2025: Kenneth J. Widder (Director) sold 4,026 shares, about $111,963. Source: https://www.sec.gov/Archives/edgar/data/1906324/000106516825000005/0001065168-25-000005-index.htm
- Nov 24, 2025: Joseph M. Busky (Chief Financial Officer) bought 4,770 shares, about $124,306. Source: https://www.sec.gov/Archives/edgar/data/1906324/000138509125000005/0001385091-25-000005-index.htm
- Nov 21, 2025: Mary Lake Ph D. Polan (Director) bought 1,000 shares, about $22,430. Source: https://www.sec.gov/Archives/edgar/data/1906324/000118771625000006/0001187716-25-000006-index.htm
- Nov 19, 2025: Brian J. Blaser (President and CEO) bought 23,500 shares, about $501,490. Source: https://www.sec.gov/Archives/edgar/data/1906324/000149228925000006/0001492289-25-000006-index.htm

## What management said

- "The underlying performance of our Labs and Immunohematology businesses remained solid in the third quarter, supported by the strength and durability of our customer relationships and our large global installed base" Brian J. Blaser, President and Chief Executive Officer of QuidelOrtho (8-K filed Nov 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000040/qdel9272026ex991earningsre.htm

## Latest filings

- 8-K filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000040/qdel-20261103.htm
- 10-K filed Feb 19, 2026: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000008/qdel-20251228.htm
- 10-Q filed Aug 7, 2026: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000033/qdel-20260628.htm
- DEF 14A filed Apr 27, 2026: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000018/qdel-20260427.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/